[Clinical significance of the level of circulating immune complexes in patients with small cell bronchial carcinoma].
In the sera of 58 bronchial cancer patients with different TNM progression stage the relative 125I-C1q binding activities (BA) were determined before, after an induction of polychemotherapy and after a simultaneous polychemo- plus X-rays therapy. Only a statistically non-significant decrease of the 125I-C1q-BA was measured in the sera of patient groups with a stronger metastatic spread in the regional lymph nodes or distant metastasis. The tumor therapy cycles changed the serum 125I-C1q-BA differently and non significantly. The determination of serum 125I-C1q-BA of bronchial cancer patients is not relevant clinically.
Malberg
K
K
Abteilung für Medizinische Immunologie, Medizinischen Akademie, Erfurt.
Prokop
D
D
von Paris
V
V
D000936:Antigen-Antibody Complex / Q000097:blood*; D001984:Bronchial Neoplasms / Q000175:diagnosis / Q000276:immunology*; D018288:Carcinoma, Small Cell / Q000175:diagnosis / Q000276:immunology*; D015922:Complement C1q / Q000378:metabolism; D006801:Humans
D000936:Antigen-Antibody Complex; D015922:Complement C1q
Klinische Relevanz der Bestimmung zirkulierender Immunkomplexe bei Patienten mit kleinzelligem Bronchialkarzinom.